Literature DB >> 25892619

Evaluation of the repeated-dose liver and gastrointestinal tract micronucleus assays with 22 chemicals using young adult rats: summary of the collaborative study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/The Japanese Environmental Mutagen Society (JEMS) - Mammalian Mutagenicity Study Group (MMS).

Shuichi Hamada1, Wakako Ohyama2, Rie Takashima3, Keisuke Shimada4, Kazumi Matsumoto5, Satoru Kawakami6, Fuyumi Uno7, Hajime Sui8, Yasushi Shimada9, Tadashi Imamura10, Shoji Matsumura11, Hisakazu Sanada12, Kenji Inoue13, Shigeharu Muto14, Izumi Ogawa15, Aya Hayashi16, Tomomi Takayanagi17, Yosuke Ogiwara18, Akihisa Maeda19, Emiko Okada2, Yukari Terashima20, Hironao Takasawa3, Kazunori Narumi2, Yumi Wako3, Kazufumi Kawasako3, Masaki Sano7, Nobuyuki Ohashi7, Takeshi Morita21, Hajime Kojima21, Masamitsu Honma21, Makoto Hayashi7.   

Abstract

The repeated-dose liver micronucleus (RDLMN) assay using young adult rats has the potential to detect hepatocarcinogens. We conducted a collaborative study to assess the performance of this assay and to evaluate the possibility of integrating it into general toxicological studies. Twenty-four testing laboratories belonging to the Mammalian Mutagenicity Study Group, a subgroup of the Japanese Environmental Mutagen Society, participated in this trial. Twenty-two model chemicals, including some hepatocarcinogens, were tested in 14- and/or 28-day RDLMN assays. As a result, 14 out of the 16 hepatocarcinogens were positive, including 9 genotoxic hepatocarcinogens, which were reported negative in the bone marrow/peripheral blood micronucleus (MN) assay by a single treatment. These outcomes show the high sensitivity of the RDLMN assay to hepatocarcinogens. Regarding the specificity, 4 out of the 6 non-liver targeted genotoxic carcinogens gave negative responses. This shows the high organ specificity of the RDLMN assay. In addition to the RDLMN assay, we simultaneously conducted gastrointestinal tract MN assays using 6 of the above carcinogens as an optional trial of the collaborative study. The MN assay using the glandular stomach, which is the first contact site of the test chemical when administered by oral gavage, was able to detect chromosomal aberrations with 3 test chemicals including a stomach-targeted carcinogen. The treatment regime was the 14- and/or 28-day repeated-dose, and the regime is sufficiently promising to incorporate these methods into repeated-dose toxicological studies. The outcomes of our collaborative study indicated that the new techniques to detect chromosomal aberrations in vivo in several tissues worked successfully.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gastrointestinal tract; Hepatocarcinogen; Integration; Liver; Micronucleus; Repeated-dose

Mesh:

Substances:

Year:  2015        PMID: 25892619     DOI: 10.1016/j.mrgentox.2015.01.001

Source DB:  PubMed          Journal:  Mutat Res Genet Toxicol Environ Mutagen        ISSN: 1383-5718            Impact factor:   2.873


  11 in total

1.  Amelioration of hepatic function, oxidative stress, and histopathologic damages by Cassia fistula L. fraction in thioacetamide-induced liver toxicity.

Authors:  Sandeep Kaur; Dipakshi Sharma; Amrit Pal Singh; Satwinderjeet Kaur
Journal:  Environ Sci Pollut Res Int       Date:  2019-08-13       Impact factor: 4.223

2.  Flow cytometric method for scoring rat liver micronuclei with simultaneous assessments of hepatocyte proliferation.

Authors:  Svetlana L Avlasevich; Sumee Khanal; Priyanka Singh; Dorothea K Torous; Jeffrey C Bemis; Stephen D Dertinger
Journal:  Environ Mol Mutagen       Date:  2018-01-22       Impact factor: 3.216

3.  Integration of liver and blood micronucleus and Pig-a gene mutation endpoints into rat 28-day repeat-treatment studies: Proof-of-principle with diethylnitrosamine.

Authors:  Sumee Khanal; Priyanka Singh; Svetlana L Avlasevich; Dorothea K Torous; Jeffrey C Bemis; Stephen D Dertinger
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2018-02-23       Impact factor: 2.873

4.  Development of reconstructed intestinal micronucleus cytome (RICyt) assay in 3D human gut model for genotoxicity assessment of orally ingested substances.

Authors:  Hui Kheng Lim; Christopher Owen Hughes; Michelle Jing Sin Lim; Jia'En Jasmine Li; Moumita Rakshit; Calvin Yeo; Kern Rei Chng; Angela Li; Joanne Sheot Harn Chan; Kee Woei Ng; David Ian Leavesley; Benjamin Paul Chapman Smith
Journal:  Arch Toxicol       Date:  2022-02-28       Impact factor: 6.168

5.  Evaluation of a 4-day repeated-dose micronucleus test in rat glandular stomach and colon using aneugens and non-genotoxic non-carcinogens.

Authors:  Emiko Okada; Yohei Fujiishi; Kazunori Narumi; Wakako Ohyama
Journal:  Genes Environ       Date:  2022-04-11

Review 6.  The micronucleus test-most widely used in vivo genotoxicity test.

Authors:  Makoto Hayashi
Journal:  Genes Environ       Date:  2016-10-01

7.  Effectiveness of the liver micronucleus assay using juvenile mice.

Authors:  Ritsuko Nagasue; Ikue Murata; Kazuaki Sasaki; Rina Sakai; Hirofumi Miyajima; Minoru Shimoda
Journal:  J Vet Med Sci       Date:  2017-07-11       Impact factor: 1.267

8.  Evaluation of the novel liver micronucleus assay using formalin-fixed tissues.

Authors:  Shuichi Hamada; Miyuki Shigano; Satoru Kawakami; Maya Ueda; Hajime Sui; Katsuya Yamada; Soichiro Hagio; Ayaka Momonami; Akihisa Maeda; Yukari Terashima; Wakako Ohyama; Takeshi Morita; Makoto Hayashi
Journal:  Genes Environ       Date:  2019-05-09

9.  Genotoxicity assessment in two Amazonian estuaries using the Plagioscion squamosissimus as a biomonitor.

Authors:  Claudia Antonia Campos Rodrigues de Oliveira; Paulo Sérgio Dos Santos Souto; Dulcidéia da Conceição Palheta; Marcelo de Oliveira Bahia; Lorena da AraújoCunha; Maria de Lourdes Souza Santos; Tatiane do Nascimento Medeiros Rodrigues; Bianca Bentes
Journal:  Environ Sci Pollut Res Int       Date:  2022-01-28       Impact factor: 5.190

10.  Detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies.

Authors:  Shuichi Hamada; Miyuki Shigano; Yumi Wako; Kazufumi Kawasako; Kensuke Satomoto; Tatsuya Mitsumoto; Takayuki Fukuda; Wakako Ohyama; Takeshi Morita; Makoto Hayashi
Journal:  Genes Environ       Date:  2022-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.